Precision BioSciences to Present In Vivo Gene Therapy and Ex Vivo Cancer Immunotherapy Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

DURHAM, North Carolina, USA, May 14 2018 – Precision BioSciences, the ARCUS genome editing company with novel product development programs in gene therapy, cancer immunotherapy and non-GMO food,...


Cargill announces ongoing partnership with Precision BioSciences enabling healthy canola oil products

Durham, NC Feb. 22, 2018 – Cargill today announced an ongoing partnership with Precision BioSciences to advance its program in healthy canola oils with the lowest saturate levels on the market...


Precision CEO Matt Kane Discusses the Unique Features of ARCUS with PMWC

  On January 22nd 2018, Precision BioSciences CEO and Co-founder Matt Kane will participate in the Silicon Valley Precision Medicine World Conference (PMWC), sharing his insights as part of...